Compare Genuine Parts Company (GPC) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs Johnson & Johnson — how do they compare? Genuine Parts Company trades at $135.29 (market cap $18.47B), while Johnson & Johnson trades at $262.01 (market cap $628.65B). The key difference: Johnson & Johnson is far larger — about 34× Genuine Parts Company's market cap, and Genuine Parts Company pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| GPC | JNJ | |
|---|---|---|
Market Cap | $18.47B | $628.65B |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $267.24 |
52-Week Low | $92.47 | $174.16 |
Enterprise Value | $24.57B | $656.92B |
Dividend Yield | 3.17% | 2.05% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GPC trades at $135.35, up 0.19% today, with a bullish technical signal supported by moving averages and a recent golden cross. The company reported Q2 2026 earnings of $2.15 per share, beating estimates, and maintains a quarterly dividend of $1.06. Revenue growth is steady, but net income margins are thin at 0.13%, and the P/E ratio is elevated at 536.04, indicating high valuation relative to earnings.
Outlook is mixed: analyst consensus is a buy with a $148.67 price target, but profitability concerns and rising debt-to-asset ratios pose risks. The stock's upside depends on sustained industrial segment strength and margin improvement amid inflationary pressures.
Johnson & Johnson (JNJ) trades at $262.08, up 0.88% with a bullish technical outlook supported by moving averages. The company demonstrates strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend growth spanning 64 years. Recent earnings show beats in Q1 and Q2 2026, while analysts maintain a buy consensus with a $284.50 price target representing 8.5% upside potential.
JNJ offers stable growth with defensive characteristics but faces headwinds from patent expirations and legal challenges. The stock trades at a premium valuation (P/E 30.26) but justifies it with robust profitability (ROE 25.74%). Current price near 52-week highs suggests limited near-term upside without new catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
